Stage III Colon Cancer

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer

Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients

Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer

French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)

Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER

LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer

Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer

Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colon Cancer

Real-world Retrospective Data Analysis of Adjuvant Therapy for Patients With Stage II-III Colon Cancer After Radical Surgery

Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer

Exercise and Colon Cancer

Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer

Prognostic Value of the Immunoscore® Colon Test for Disease Free Survival Stratification in Stage III Patients Under Oxaliplatin Treatment

Low Glycemic Load Diet in Patients With Stage I-III Colon Cancer

Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer